2016 Global Survey on Clinical Next-Generation Sequencing

Thursday, January 26, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Jan. 25, 2017 /PRNewswire/ --Respondents Show Vivid Interest in Developing Clinical NGS-based Tests for Infectious Disease Testing Applications

The primary goal of this research is to analyze the current and future adoption plans of Next-Generation Sequencing (NGS) for clinical applications. The survey seeks to collect the following key information:- Outsourcing needs and clinical
NGS service providers- Current and future interest areas of clinical NGS- Genetic elements of interest- Purchase patterns for instruments and reagents- Predominantly used clinical methods (e.g., chip sequencing, whole exome)- Perspectives of NGS used as complement or replacement for current methods- Platforms used for NGS clinical data interpretation- Predominantly cited instruments for clinical use- Familiarity with clinical NGS service providers- Factors promoting adoption- Factors limiting adoption- Best practices from labs—direct quotes from lab managersResearch MethodologyLab managers of clinical labs were invited to participate in an online survey during August–November 2016. To qualify for survey participation, respondents had to be working in a private or public laboratory, clinical research institution, reference laboratory, academic medical center facility, hospital lab, or diagnostic company that employs NGS for clinical use. Respondents had to be constant users of this technology, belong to the scientific community, and be in a position to authorize purchases. Over 184 respondents qualified for the survey including C-level officers, lab managers, directors, physicians, post docs, and principal investigators that had a direct interference with the clinical NGS community. End users were also evaluated for their ability to authorize purchases or make product recommendations. Respondents indicated a wide range of job titles, such as lab directors, scientists, lab managers, clinicians, pathologists, and lab technicians. In total, about 82% of respondents work in the United States. Nevertheless, this study is considered global because the survey was open to respondents from all countries.Read the full report: http://www.reportlinker.com/p04636275-summary/view-report.htmlAbout Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.http://www.reportlinker.com__________________________Contact Clare: [email protected]US: (339)-368-6001Intl: +1 339-368-6001

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/2016-global-survey-on-clinical-next-generation-sequencing-300396848.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook